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Abstract 
 
In this work, the coating of 3-D foam-like glass-ceramic scaffolds with a bioactive mesoporous 
glass (MBG) was investigated. The starting scaffolds, based on a non-commercial silicate glass 
(SCNA), were fabricated by the polymer sponge replica technique followed by sintering; then, 
electrophoretic deposition (EPD) was applied to deposit a MBG layer on the scaffold struts. EPD 
was also compared with other techniques (dipping and direct in situ gelation) and it was shown to 
lead to the most promising results. The scaffold pore structure was maintained after the MBG 
coating by EPD, as assessed by SEM and micro-CT. In vitro bioactivity of the scaffolds was 
assessed by immersion in simulated body fluid (SBF) and subsequent evaluation of hydroxyapatite 
(HA) formation. The deposition of a MBG coating can be a smart strategy to impart bioactive 
properties to the scaffold, allowing the formation of nano-structured HA agglomerates within 48 h 
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from immersion, which does not occur on uncoated scaffold surfaces. The mechanical properties of 
the scaffold do not vary after the EPD (compressive strength ~19 MPa, fracture energy ~1.2×106 J 
m-3) and suggest the suitability of the prepared highly bioactive constructs as bone tissue 
engineering implants for load-bearing applications.   
 
Keywords: Electrophoresis; Scaffold; Mesoporous glass; Bioactivity; Bone tissue engineering. 
 
1. Introduction 
 
Since the invention of 45S5 Bioglass® by Hench and co-workers in 1969 [1], bioactive glasses and 
glass-ceramics have been widely investigated as ideal materials for bone tissue engineering 
applications due to their ability to form an interfacial bond with host tissues [2] and to stimulate via 
ion release the genes of cells towards a path of regeneration and self-repair [3]. Over the last three 
decades, 45S5 Bioglass® has been marketed worldwide for clinical use in the form of cast structures 
to replace the middle ear bones, fine particulate to fill periodontal defects, porous granules and 
mouldable or injectable paste for orthopaedic applications [4]. 45S5 Bioglass® was also 
experimented to produce 3-D porous scaffolds able to allow tissue in-growth in their porous 
network. In this regard, the first study was reported in 2001 by Yuan et al. [5], who implanted 
porous Bioglass®-derived glass-ceramic cylinders in dogs; only a small amount of new bone was 
detected within the implants (around 3% of the pores area on optical cross-sections) as the porosity 
obtained by H2O2 foaming was low (~32 vol.%) and poorly interconnected. Chen et al. [6] and 
Vitale-Brovarone et al. [7] pioneered the use of the sponge replication method to fabricate highly 
porous (85-90 vol.%) Bioglass® scaffolds able to allow tissue and blood vessels in-growth; 
however, these scaffolds were too brittle (compressive strength within 0.3-0.4 MPa [6], 1 MPa [7]) 
to deem any real surgical application. The combination of PE particles and a polymeric sponge as 
pore formers [8] as well as various optimization strategies [9] were also reported in the attempt at 
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improving the mechanical performance of Bioglass® scaffolds, but problems of brittleness still 
remained. This was one of the major reasons why other bioactive glass formulations were 
developed in recent years in the hope that a truly strong, bioactive glass scaffold can be eventually 
produced. As emphasized in some recent studies [10-12], the design of an appropriate bioactive 
glass composition for scaffolding is a complex task to achieve, being a combination of different 
competing issues. Indeed, a scaffold must guarantee an appropriate surface reactivity and 
accordingly a good bioactivity, as well as a favourable sinterability versus sufficient crystallization, 
which is a key parameter to consider for obtaining well-densified, strong struts of the scaffold; in 
addition an intrinsic mechanical strength of the material is required. 
In some recent studies, the authors developed a biocompatible silicate glass (SCNA) in the SiO2-
CaO-Na2O-Al2O3 system and reported various evidences supporting its mechanical suitability for 
bone repair applications even in load-bearing conditions [13-15]; on the other hand, however, 
SCNA is characterized by low bioactive properties. In this work, a novel approach to produce a 
high-strength and bioactive scaffold for bone replacement is disclosed: SCNA scaffold is designed 
to act as a macroporous substrate on which a highly bioactive coating of mesoporous glass is 
deposited through electrophoresis. This approach is useful to overcome the limitation of dramatic 
brittleness of foam-like scaffolds fully constituted of mesoporous bioactive glass (MBG) 
(compressive strength around 0.05-0.15 MPa [16,17]), which is unavoidably due to the presence of 
a high, intrinsic mesoporosity of the material. Electrophoretic deposition (EPD) is a special 
colloidal processing technique that uses the electrophoresis mechanism for the movement of 
charged particles suspended in a solution under an electric field, with the aim of depositing them on 
a substrate to develop coatings of adjustable thickness [18]. EPD is characterized by high versatility 
in terms of the broad range of materials (in particulate form) to which it can be applied and the 
relatively simple, inexpensive equipment required. The application of EPD in the biomaterials field 
started with the development of hydroxyapatite (HA) coatings on titanium substrates in the 1980s 
[19], gaining further impetus one decade later with the work of Zhitomirsky and Gal-Or [20], which 
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was fundamental for the EPD of HA nanoparticles. Krause et al. [21] were the first to have 
investigated the EPD of 45S5 Bioglass® powder (particle size below 3 µm) from aqueous 
suspensions. Roether et al. [22] applied EPD to coat 3-D porous poly(lactic acid) substrates with 
45S5 Bioglass® particles and Boccacini et al. [23] showed that polyetheretherketone 
(PEEK)/Bioglass® composite coatings can be produced via EPD on nickel-titanium shape memory 
alloy wires. In the last few years there has been a considerable increase in research efforts to apply 
EPD to produce polymer/nano-sized bioactive glass composite coatings with enhanced 
multifunctional properties (e.g. bone-bonding ability and drug release in situ via polymer 
degradation) [24]. The use of EPD to produce carbon nanotubes (CNTs) coatings has been also 
investigated: for example, Meng et al. [25] incorporated CNTs into Bioglass® macroporous foams 
by EPD and cultured mesenchymal stem cells on the constructs with and without electrical 
stimulation, and they observed that the electrical conductivity associated to the CNTs can promote 
the proliferation and differentiation of the cells attached onto the scaffold. Therefore, the 
applications of EPD in the biomedical sector are being expanded to include a variety of functional, 
nanostructured and composite coatings with the aim to impart smart added values to biomaterials. 
To the best of the authors’ knowledge, to date the EPD of MBGs has been never reported; thus, this 
work represents a pilot study that could provide a significant incentive to the development of a new 
procedure to prepare bioactive scaffolds for bone tissue engineering. 
 
2. Materials and methods 
 
2.1. Macroporous scaffolds fabrication 
 
Bone-like macroporous scaffolds were produced using a quaternary silicate glass (SCNA; 57SiO2-
34CaO-6Na2O-3Al2O3 mol.%) as a starting material. SCNA reagents (high-purity powders of SiO2, 
CaCO3, Na2CO3 and Al2O3 purchased from Sigma-Aldrich) were molten in a platinum crucible at 
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1550 °C for 1 h in air; the melt was quenched in cold water to obtain a frit, that was subsequently 
ground by using a 6-balls zirconia milling jar and manually sieved (Giuliani stainless steel sieve) to 
obtain particles with size below 32 µm. The sponge replication method was adopted for fabricating 
the scaffolds due to its excellent suitability to obtain porous ceramics with a highly-interconnected 
3-D network of open macropores [26]. Small cubic blocks (10.0 mm × 10.0 mm × 10.0 mm) of a 
commercial open-cells polyurethane (PU) sponge (density of the porous polymer ∼20 kg m-3) were 
coated with SCNA powder by impregnation in a water-based glass slurry (glass : distilled water : 
poly(vinyl alcohol) (PVA) = 30 : 64 : 6 wt.%). After PVA hydrolysis under continuous magnetic 
stirring at 80 °C, SCNA powder was added to the solution; the water evaporated during PVA 
dissolution was re-added to the slurry to restore the correct weight ratios among the components. 
After further stirring for 15 min at room temperature to ensure slurry homogeneity, the sponge 
blocks were immersed for 60 s in the slurry. The slurry infiltrated the porous network of the PU 
template that was extracted from the slurry and subsequently compressed (50 kPa for 1 s) up to 60% 
in thickness along three orthogonal spatial directions, in order to homogeneously remove the excess 
slurry. This infiltration/compression cycle was repeated for three times; then, a final cycle of 
impregnation without subsequent compression was performed. The samples were dried at room 
temperature overnight and afterwards thermally treated at 1000 °C for 3 h (heating and cooling rates 
set at 5 and 10 °C min-1, respectively) in order to burn-off the polymeric template and to sinter the 
inorganic particles. As reported elsewhere [27], one crystalline phase (wollastonite, CaSiO3) forms 
during the above-mentioned heat treatment; however, for the sake of simplicity, the expression 
“SCNA scaffold” will be hereafter adopted, without further specifying the glass-ceramic nature of 
the sintered material. SCNA scaffolds were eventually coated by MBG following three different 
procedures, as described in the section 2.3. 
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2.2. MBG synthesis procedure 
 
The mesostructured glass to be deposited on the macroporous SCNA scaffolds was produced by 
coupling a traditional sol-gel method with the evaporation-induced self-assembly (EISA) process, 
following a synthesis procedure reported elsewhere [28] wherein an amphiphilic triblock copolymer 
with sequence poly(ethylene glycole)-poly(propylene glycole)-poly(ethylene glycole) (PEG-PPG-
PEG), commercially called Pluronic 123 (P123), was used as a structure directing agent. Briefly, 
2.0 g of P123 (Mw = 5800 Da; Aldrich) were dissolved in 60.0 g of ethanol (99.5%, Sigma-Aldrich) 
and 1.0 g of 0.5 M HCl. After continuous magnetic stirring (300 rpm) at 35 °C for 1 h till P123 is 
completely dissolved, the glass oxides precursors, i.e. 6.7 g of tetraethyl orthosilicate (TEOS; 
98.0%, Sigma-Aldrich), 0.73 g of triethyl phosphate (TEP; 99.8%, Sigma-Aldrich) and 1.4 g of 
calcium nitrate tetrahydrate (Ca(NO3)2⋅4H2O; Sigma-Aldrich) (molar ratio SiO2 : CaO : P2O5 = 80 : 
15 : 5), were added to the synthesis batch (pH < 1.0). The batch was continuously stirred at 35 °C 
for 24 h; then, the sol was cast into Petri dishes to undergo the EISA process at room temperature. 
The gelation occurred by ~36 h; after 7 days of ageing, the dried gels were carefully removed from 
the moulds as transparent membranes and finally calcined at 700 °C in air for 5 h (heating and 
cooling rates set at 1 and 10 °C min-1, respectively). The glass membranes were then ground and 
sieved below 20 µm to obtain a suitable powder for EPD, for which the use of particles with size 
below 30 µm is recommended [29]. 
 
2.3. MBG coating deposition  
 
2.3.1. Electrophoretic deposition (EPD) 
 
The suspension for EPD was prepared by adding to acetone the sieved MBG powder at a 
concentration of 3 g L-1. The resulting suspension was sonicated in an ultrasonic bath for 10 min to 
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favour the powder dispersion. The EPD was performed using an experimental set-up similar to that 
reported by Boccacini et al. [30], where the two electrodes are placed in the suspension with the 
scaffold suspended, through a clamp, in the centre of the EPD cell. The scaffold was placed in such 
a way that the larger pores were oriented perpendicularly to the surface of the electrodes, and thus 
to the particles flow. The electrodes, made of platinum foils with dimensions of 15 mm × 15 mm × 
0.2 mm, were connected to a dc power supply. EPD was carried out by setting a constant voltage of 
200 V, with deposition time of 5 min and electrode separation of 40 mm. After the EPD process, the 
scaffold was carefully and slowly withdrawn from the EPD cell, dried at room temperature 
overnight, and then thermally treated at 500 °C (heating rate: 10 °C min-1) for 5 h to favour the 
anchoring of incorporated MBG particles to the scaffold walls. 
 
2.3.2. Comparative methods: dipping and direct in situ gelation  
 
In addition to the EPD, two other approaches were experimented to coat SCNA macroporous 
scaffolds with MBG; it is worth anticipating here that both these alternative strategies resulted 
unsuccessful, but the relevant results are reported in this work to further emphasize the potential of 
EPD for the intended application. 
The first approach consisted of dipping the scaffold for 10 min in a suspension of MBG in acetone 
at the same concentration used for the EPD, but without applying a voltage, to elucidate the role of 
the latter in determining the coating features. The scaffold was thermally treated in the same way as 
reported in the section 2.3.1. 
The second approach consisted of driving the MBG incorporation inside the porous scaffold by 
casting the sol into a Petri dish containing the scaffold till it was completely submerged. In this 
way, gelation is expected to occur inside scaffold macropores filled with the sol; after 48 h, the 
scaffold was extracted from the surrounding gel (the soft membrane was manually cut with a 
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lancet), underwent an ageing phase of 7 days and was finally calcined as reported for the MBG as 
such (see the section 2.2)    
 
2.4. Characterization 
 
2.4.1. Morphological and structural characterization 
 
The scaffolds were metal-coated (chromium or silver), and their morphology and porous 3-D 
architecture were investigated by scanning electron microscopy (JEOL-JX-A8600). The inner 
porous network of the constructs produced by EPD was also non-destructively investigated by 
micro-computed tomography (micro-CT; SkyScan 1174, Micro Photonics Inc.; maximum 
resolution: 6.5 µm) to assess the pores content and interconnectivity (CTAn software). 3-D 
reconstruction and visualization were performed using NRecon and DataViewer/CTVox softwares, 
respectively. For the purpose of comparison, the total porosity of the scaffolds was also calculated 
through mass-volume measurements as ( ) 1001 0 ×− ρρ s , wherein ρs is the scaffold density 
(mass/volume ratio) and ρ0 is the density of bulk material.  
The MBG was investigated by means of wide-angle (2θ within 10-70°) and low-angle (2θ within 
0.8-4°) X-ray diffraction (XRD, X’Pert Philips diffractometer with Bragg-Brentano camera, Cu 
anode, and Kα radiation). The X-ray pattern (data not reported) shows an evident peak around 2θ = 
1.5°, which leads to a d-spacing equal to 5.8 nm, and a broad halo within the range 2θ = 20-30°, 
typical of silicate glasses. Nitrogen adsorption-desorption measurement at 77 K (Quantachrome 
Autosorb1) performed on the MBG ground in powder revealed a typical IV type isotherm 
(supporting information S1). The specific surface area (SSA), assessed by using the Brunauer-
Emmet-Teller (BET) method, resulted 307 m2/g, whereas the pores diameter determined through 
the DFT (Density Functional Theory) method, using the NLDFT equilibrium model [31], was 4.7 
nm.  
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Compositional investigations were performed by energy dispersive spectroscopy (EDS; Philips 
Edax 9100). 
 
 
2.4.2. In vitro bioactivity 
 
In the context of silicate glasses for bone regeneration (like those investigated in the present study), 
the expression “inorganic bioactivity” or simply “bioactivity” refers to the formation of a HA or 
HA-like layer on the surface of the material after contact with biological fluids. The scaffold 
bioactive properties were assessed by soaking the samples in an acellular simulated body fluid 
(SBF) prepared according to the Kokubo’s protocol [32], which is currently considered as a reliable 
standard medium for assessment of biomaterials behaviour in vitro. 
MBG-coated and as-such SCNA scaffolds were soaked in 30 ml of SBF contained in PE bottles and 
maintained at 37 °C in an incubator for 24 h and 48 h, in order to investigate the modifications of 
the material surface in the short term. At the end of the experiment, the samples were gently washed 
with distilled water, dried at room temperature, chromium-coated and investigated by SEM and 
EDS. 
 
2.4.3. Mechanical testing   
 
The compressive failure stress σc (MPa) was evaluated through crushing tests (Syntech 9/D testing 
machine, 44-kN load cell, cross-head speed set at 1 mm min-1) as: 
R
M
c A
L
=σ                                                                       (1) 
wherein LM (N) is the maximum load registered during the test and AR (mm2) is the resistant cross-
sectional area. 
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The energy per unit volume VE  (J m-3) absorbed by the scaffold till the breaking off is reached was 
defined as the energy necessary to deform a specimen from the unloaded condition to the failure 
strain εf, and was calculated as the area under the stress-strain curve up to εf [33]: 
εεσ
ε
∫=
f
dEV
0
)(                                                                (2) 
wherein the strain ε denotes the integration variable; the initial and final conditions are, 
respectively, 0)0( ==εσ  and cf σεεσ == )(  (calculated from Eq.(1)). 
The above-mentioned mechanical parameters were expressed as mean value ± standard deviation 
calculated on seven samples (≈ 7 mm × 7 mm × 5 mm cuboids) for each type. 
 
3. Results and discussion 
 
3.1. Morphology 
 
Figure 1a reports a SEM micrograph of a thermally-treated SCNA scaffold, which is a successful 
replica of the porous polymeric template. The strut architecture, with open and interconnected 
macropores having size above 100 µm, closely mimics the 3-D trabecular structure of human 
cancellous bone [34]. The glass-ceramic nature of sintered SCNA is confirmed by Fig. 1b, showing 
the micro-rough appearance of a scaffold trabecula due to the presence of needle-like crystals 
developed during the thermal treatment. According to previous works, this crystalline phase can be 
identified as CaSiO3 (wollastonite), as confirmed by the compositional analysis (Fig. 1c).  
Figures 2a and 2b show SCNA scaffold after the EPD and thermal treatment at lower and higher 
magnification, respectively. At the micro-scale, scaffold pore walls and struts appear covered by a 
rather dense and uniform layer of MBG micro-sized particles, without large agglomeration 
occluding the macroporous structure. The corresponding EDS spectrum is reported in Fig. 2c: 
besides the peaks of silicon (Si) and calcium (Ca), also detected for the scaffold as such, the signal 
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due to phosphorus (P) is observed, as expected on the basis of the MBG composition. Detection of a 
signal due to phosphorus (P) is a clear evidence of the incorporation of MBG particles inside the 
SCNA scaffold, as the composition of the latter (57SiO2-34CaO-6Na2O-3Al2O3 mol.%) does not 
imply the presence of P. 
For the purpose of comparison, the results of the other two (unsuccessful) strategies experimented 
in the attempt to incorporate MBG inside the scaffold are illustrated in Figures 3 and 4. Figure 3 
shows SCNA scaffold after dipping in MBG suspension: the macropores surface appears mostly 
uncovered and quite large aggregates (about 20-30 µm) of MBG particles are observed in few 
cavities. It appears that, through dipping approach, very low amount of MBG can be loaded inside 
SCNA macropores and that the few incorporated particles tend to assemble into cavities and 
coalesce during thermal treatment. EDS analysis performed on these aggregates (Figure 3c) shows, 
as in the case of MBG incorporated by EPD, the presence of the phosphorus (P) signal. 
On the other hand, the strategy of submerging the scaffold within the sol led to an excessive 
incorporation of MBG, as shown in Fig. 4. Before calcination, the outer surface of the scaffold was 
coated by a thick layer that apparently obstructed the pores, which made undetectable the 
macroporous network lying underneath. After the thermal treatment, the problem persisted since a 
thick, fragmented coating of MBG enveloped the SCNA scaffold and occluded the macropores. 
Such a situation precludes any biomedical suitability of the device, as the scaffold macropores 
would not be accessible by biological fluids.  
Micro-CT investigations, carried out on the samples processed by EPD, revealed that there was no 
difference between SCNA scaffold as such and MBG-coated SCNA scaffold in terms of total 
porosity (total pore contents of 50.9 and 51.6 vol.% were determined, respectively). These findings 
are consistent with SEM observations, which showed the presence of a thin MBG coating on 
scaffold struts without pore occlusion. Density measurements substantially confirmed the 
assessments by micro-CT (mean total porosities of 53.3 and 53.8 vol.% were found for the scaffold 
as such and the MBG-coated scaffold, respectively). Therefore, the deposition of a MBG thin 
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coating on scaffold struts via EPD does not involve decrement in the scaffold porosity, that remains 
unaltered with respect to non-coated samples.   
The total porosity of the prepared constructs is within the range recommended for bone tissue 
engineering scaffolds (50-80 vol.% [35]), although very close to the lower threshold. The scaffolds 
had good 3-D pores interconnectivity throughout the whole volume with open porosity calculated 
by CTAn software above 95% of the overall pores content, which is a key feature after in vivo 
implantation in order to have paths for cells to migrate, tissue to grow in and waste products to flow 
out. 
Micro-CT was also used to assess in a non-destructive way whether the coating was homogeneously 
and continuously deposited on the struts throughout the scaffold volume. The instrument available 
for the analysis exploited a polychromatic X-ray radiation and, therefore, the discrimination 
between materials with similar density (SCNA and MBG) was quite difficult; however, after careful 
post-processing of the reconstructed images, valuable results have been obtained. Figure 5 reports 
the density mapping along different cross-sections of a MBG-coated SCNA scaffold depending on 
the different X-ray absorption of the involved materials. The presence of MBG (green colour) is 
clearly visible in the outer regions of the scaffold volume (periphery), including both the zones 
underneath the scaffold surfaces perpendicular to the EPD flow and the top and bottom faces of the 
scaffold (planes parallel to the EPD flow). In the micro-CT reconstructions, the scaffold core is 
mainly characterized by the colour blue, which indicates the presence of SCNA as the predominant 
material. Therefore, we can propose that, moving from the outer surfaces to the core, the MBG 
coating deposited on scaffold struts becomes progressively thinner; it is not possible to exclude its 
presence in the inner region as it could be thinner than 6.5 µm, which is the best resolution 
achievable with the used micro-CT equipment, or too discontinuous to be detectable.          
 
3.2. Bioactive properties 
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The need for a bioactive coating to be deposited on SCNA scaffold struts is due to the very poor 
ability of this material to induce the formation of HA on its surface upon immersion in biological 
fluids. As shown in Figure 6, even after a long-term soaking in SBF (1 month) the formation of a 
HA layer did not occur and only the presence of sparse calcium phosphate ultrafine particles can be 
detected. As reported in literature [1], the bioactive process is a sequence of ion-exchange 
phenomena occurring between the scaffold material and biological fluids; in the present case, the 
partial substitution of Si4+ with Al3+ ions in the Al2O3-rich residual glass phase of sintered glass-
ceramic SCNA (the crystalline phase is wollastonite, CaSiO3) led to a chemically stable network that 
is barely prone to react with the surrounding fluids. Upon soaking, a thin layer of silica gel formed 
on scaffold struts, through which it was possible to detect the shape of the wollastonite crystals 
lying underneath (Figure 6b). These results are consistent with the observations reported by Kokubo 
et al. [36] for Al2O3- and wollastonite-containing biomedical glass-ceramics. 
Figure 7a reports a SEM micrograph of MBG-coated SCNA scaffold surface after soaking for 48 h 
in SBF: it shows a thin layer of silica gel (as in the case of SCNA scaffold as such, see Figure 6) on 
which newly-formed agglomerates (size within 1-2 µm) characterized by a “cauliflower” 
morphology are well distinguishable. Figure 7b shows that these globular agglomerates are 
constituted by needle-like nano-crystals, and the corresponding EDS analysis on these precipitates 
(Figure 7c) reveals the presence of calcium and phosphorus with atomic ratio of 1.60 (the high peak 
of Si visible in the spectrum is due to boundary effects associated to the presence of the thin silica 
gel layer and SCNA substrate lying underneath). According to the literature, this newly formed 
phase can be identified as HA: in fact, it is widely reported that precipitates of Ca-deficient HA 
(Ca/P atomic ratio lower than 1.67, which is the value for stoichiometric HA) with cauliflower 
morphology typically form on the surface of bioactive glasses upon soaking in SBF [10, 12], as 
actually observed in the present work (Figure 7). It is worth noting that the nano-crystalline nature 
of the HA formed on MBG-coated SCNA scaffolds closely mimics the features of the biological 
apatite of bones [37], whereas synthetic HA commonly used in orthopaedics is characterized by 
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larger grain size [38]. This fact could have a significant impact on the in vivo performance of the 
scaffold once implanted, as it is known that surface nano-topography is a key factor in determining 
and mediating cell-substrate interactions [38].  
It is worth underlining that the MBG system, despite its large silica content (80 mol. %), is highly 
bioactive. Hench et al. [39] observed that, for conventional melt-derived glasses, the silica content 
has to be 60 mol. % or less to allow the bonding with bone. Nevertheless, it was demonstrated that 
bone bonding can be attained with sol-gel glasses with up to 90 mol. % of SiO2 because of their 
high surface area (approximately two orders of magnitude higher than that of melt-derived glasses), 
which allows the surface reactivity to be emphasized [40, 41]. The remarkable bioactive properties 
shown by MBG-coated SCNA scaffold are also comparable with those previously reported [28] for 
MBG membranes (with the same composition) upon soaking in SBF: also in that case, fast 
formation of HA-like globular agglomerates was observed after 48 h. This suggests that the open 
mesoporous structure is retained by the bioactive glass when deposited in form of coating by EPD, 
playing a key role in determining the performances of MBG-coated scaffold in SBF. This is also 
supported by the evidence that the bioactive kinetics observed for a non-porous bioactive glass 
coating (45S5 Bioglass®) deposited by EPD [42] on stainless steel substrates, resulted slower 
compared to those reported in the present work: in fact, the initial formation of sparse calcium 
phosphate deposits (HA precursors) was reported to occur after soaking for 5 days in SBF. In the 
present study, the electrodeposited MBG coating undergoes partial dissolution upon soaking in SBF 
due to its high reactivity, thereby accelerating the complex sequence of ion-exchange phenomena 
which lead to the final formation of HA agglomerates on the biomaterial surface (Fig. 7), as 
described in detail by Hench et al. [2]. 
Future studies on the MBG-coated SCNA scaffolds will include in vitro tests with cells; however, 
the biological compatibility of the constituent materials, i.e. MBG powders and SCNA, has been 
already demonstrated separately in previous studies [28,43], thereby suggesting the biological 
suitability of the composite system obtained through their combination. 
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3.3. Mechanical properties 
 
The data reported in Table 1 show that, from a mechanical viewpoint, there is no significant 
difference between the SCNA scaffold as such and the samples coated with MBG, which suggests 
that EPD does not damage the scaffold structure and integrity. The scaffolds compressive strength 
is above the standard reference range (2-12 MPa [39]) considered for human trabecular bone as well 
as most of foam-like scaffolds with the same porosity reported in the literature [11]; therefore, the 
produced samples can be proposed even for load-bearing applications like in joint prostheses 
[13,14]. The fracture energy is from one to two orders of magnitude higher than that reported for 
other glass-ceramic scaffolds produced by the same method and having analogous macroporous 
architecture [44,45]; in this regard, a key role is played by the formulation of the starting glass 
(SCNA) in affecting the sintering behaviour of glass particles and the densification of the scaffold 
struts.    
 
4. Conclusions  
Glass–ceramic scaffolds, belonging to the SiO2–CaO–Na2O–Al2O3 (SCNA) system, have been 
successfully coated with mesoporous bioactive glass (MBG) by the electrophoretic deposition 
technique. The MBG layer appears rather dense and uniformly distributed throughout the scaffold 
walls and struts, without occluding the macroporous structure, as assessed by SEM and micro-CT 
analyses. Alternative approaches to incorporate MBG, such as dipping and in situ gelation, resulted 
unsuccessful. The bioactivity of the MBG-coated SCNA has been assessed by the formation of 
globular agglomerates of HA nano-crystals after soaking for just 48 h in SBF, which were not 
observed on SCNA scaffolds as such even after soaking for longer periods. The mechanical 
16 
 
properties of the MBG coated-SCNA scaffold suggest their suitability as load-bearing high-strength 
grafts for bone defect restoration; furthermore, thanks to the combination of adequate porosity, high 
mechanical strength and good bioactivity, their use as smart components of joint prostheses could 
be envisaged.  
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Figure captions 
Figure 1: SCNA scaffold as such: (a) SEM micrograph of the macroporous architecture (150x); (b) 
detail of the trabeculae characterized by a surface micro-roughness due to the presence of 
wollastonite (CaSiO3) crystals (1200x); (c) EDS analysis carried out on a wollastonite crystal, 
confirming the predominant presence of Si and Ca (the presence of low peaks of Na and Al, 
contained in the residual amorphous phase, is due to boundary effects; the peak of Ag is due to the 
ultrathin metal layer deposited for SEM/EDS analysis).   
 
Figure 2: (a) SCNA scaffold coated with MBG by EPD at lower (670x) and (b) higher 
magnification (4000x); (c) EDS analysis carried out on MBG layer (the presence of low peaks of 
Na and Al is due to boundary effects of the SCNA substrate). 
 
Figure 3: (a) SCNA scaffold coated with MBG by dipping method at lower (400 x) and (b) higher 
magnification (1500x); (c) EDS analysis carried out on MBG aggregates. 
 
Figure 4: Incorporation of MBG inside SCNA scaffolds by “forced” in situ gelation: SEM 
micrographs showing (a) part of the scaffold (44x) and (b) a surface detail before calcination (the 
SCNA scaffold is completely enveloped by the gel, on which some cracks can be observed); (c) 
sample surface after calcination (60x) and (d) compositional analysis (EDS) on the MBG 
fragmented calcined coating (the peak of Ag is due to the ultrathin metal layer deposited for 
SEM/EDS analysis). 
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Figure 5: Density mapping of MBG-coated SCNA scaffold by micro-CT: (a) 3-D reconstruction of 
the central (approximately mid-length) cross-sections along the [xy], [xz] and [yz] orthogonal 
planes and (b) corresponding 2-D development; 3-D reconstruction of three cross-sections along the 
[xy], [xz] and [yz] orthogonal planes and (b) corresponding 2-D development obtained by placing 
the analysis plane perpendicular to the EPD flow in a position close to the scaffold outer surface. 
Different colours (blue and green) are associated to materials with different absorption capacity 
towards the incident X-rays. Sample dimensions: major size ~8 mm; minor sizes ~4 mm. 
 
Figure 6: SEM micrographs of as-such SCNA scaffold after soaking in SBF for (a) 7 days and (b) 
1 month (5000X).  
 
Figure 7: SEM micrographs of MBG coated SCNA scaffold after soaking in SBF for 48 h (a) at 
lower (10000x) and (b) higher magnification (150000x); (c) EDS analysis. 
 
 
 
 
 
 
 
Tables 
 
Table 1. Mechanical properties of the prepared scaffolds. 
Sample σc (MPa) EV (×106 J m-3) 
SCNA scaffold as-such 18.4 ± 3.7 1.5 ± 0.7 
MBG-coated SCNA scaffold 19.7 ± 5.5 1.2 ± 0.7 
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